Clinical Trial Detail

NCT ID NCT03131037
Title Intratumoral Gene Mediated Cytotoxic Immunotherapy in Patients With Resectable Non-Small Cell Lung Cancer
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Advantagene, Inc.
Indications

lung non-small cell carcinoma

Therapies

AdV-tk + Valacyclovir

Age Groups: senior adult

No variant requirements are available.